Pliant Therapeutics Files 2024 10-K
Ticker: PLRX · Form: 10-K · Filed: Mar 3, 2025 · CIK: 1746473
| Field | Detail |
|---|---|
| Company | Pliant Therapeutics, Inc. (PLRX) |
| Form Type | 10-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
Related Tickers: PLRX
TL;DR
Pliant Therapeutics (PLRX) filed its 2024 10-K. Financials are in.
AI Summary
Pliant Therapeutics, Inc. filed its 2024 10-K on March 3, 2025, reporting financial results for the fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is headquartered in South San Francisco, California. Key financial data and operational details for the period are outlined in the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Pliant Therapeutics' financial health and business operations for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Pliant Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Prior Fiscal Year (Comparison period for financial data)
- 2022 — Prior Fiscal Year (Comparison period for financial data)
Key Players & Entities
- PLIANT THERAPEUTICS, INC. (company) — Filer
- South San Francisco, CA (location) — Business Address
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-03 (date) — Filing Date
FAQ
What is Pliant Therapeutics' primary business focus?
Pliant Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When did Pliant Therapeutics file its 2024 10-K?
Pliant Therapeutics, Inc. filed its 2024 10-K on March 3, 2025.
Where is Pliant Therapeutics, Inc. located?
The company's business and mailing address is 331 Oyster Point Boulevard, South San Francisco, CA 94080.
What is the SEC file number for Pliant Therapeutics?
The SEC file number for Pliant Therapeutics, Inc. is 001-39303.
What is the fiscal year end for Pliant Therapeutics?
Pliant Therapeutics, Inc.'s fiscal year ends on December 31st.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 3, 2025 regarding PLIANT THERAPEUTICS, INC. (PLRX).